Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: May 2023

Sanofi announces positive data for frexalimab in relapsing MS

The neurological disease affects approximately 2.8 million people worldwide

May 31, 2023 Uncategorized

Amgen’s Otezla shows promise in psoriatic arthritis

The inflammatory form of arthritis is estimated to affect nearly 38 million people worldwide

May 31, 2023 Uncategorized

Using AI to create better, more potent medicines

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human […]

May 31, 2023 Uncategorized

When I use a word . . . Commercial clinical trials

A reviewEarlier this year, the UK government appointed Lord James O’Shaughnessy, senior partner at a consultancy firm, Newmarket […]

May 31, 2023 Uncategorized

Systemic problems in maternity services are part of wider systemic problems in the NHS in England

Wilkinson’s article1 on Kirkup’s review2 of recurring problems in maternity services highlights the cultural and systemic matters involved. […]

May 30, 2023 Uncategorized

Helen Salisbury: Rebranding our experts in family medicine

What is a GP? I suspect that if you asked a representative sample of people on the street, […]

May 30, 2023 General practice / family medicine, UK

Nigeria considers law that would prevent doctors from leaving for five years after training

Doctors’ groups in Nigeria have condemned a bill before Congress that would deny newly qualified doctors a full […]

May 30, 2023 Uncategorized

Surgeon is struck off for sexually assaulting a junior female colleague

A surgeon has been struck off the UK medical register after a tribunal found that he sexually assaulted […]

May 30, 2023 Uncategorized

EU regulator recommends revoking approval for Novartis’ sickle cell disease drug

The EMA’s human medicines committee concluded that the benefits of Adakveo did not outweigh its risks

May 30, 2023 Uncategorized

AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD

The drug has already been approved for this indication in the EU, with regulatory reviews continuing elsewhere including […]

May 30, 2023 Uncategorized

Posts navigation

Posts pagination

« Previous 1 2 3 … 24 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy